A core microbiome associated with the peritoneal tumors of pseudomyxoma peritonei

Orphanet Journal of Rare Diseases

Volumn 8, Issue 1, 2013, Pages

  Gilbreath, Jeremy J ^a   Semino Mora, Cristina ^b   Friedline, Christopher J ^c   Liu, Hui ^b   Bodi, Kip L ^d   McAvoy, Thomas J ^e   Francis, Jennifer ^f   Nieroda, Carol ^f   Sardi, Armando ^f   Dubois, Andre ^b   Lazinski, David W ^g   Camilli, Andrew ^g,h   Testerman, Traci L ⁱ   Merrell, D Scott ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b Uniformed Services University of the Health Sciences   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d TUFTS UNIVERSITY   (United States)

^e UNIVERSITY OF MARYLAND   (United States)

^f Mercy Health Services   (United States)

^g TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h HOWARD HUGHES MEDICAL INSTITUTE   (United States)

ⁱ LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Microbiome; Microbiota; Peritoneal cancer; PMP; Pseudomyxoma peritonei

Indexed keywords

AMOXICILLIN PLUS CLARITHROMYCIN PLUS LANSOPRAZOLE; MITOMYCIN; MUCIN 2;

ACTINOBACTERIA; AMPLICON; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTEROIDETES; BETAPROTEOBACTERIA; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DNA CONTAMINATION; DNA EXTRACTION; FIRMICUTES; GAMMAPROTEOBACTERIA; HUMAN; IN SITU HYBRIDIZATION; IN VITRO STUDY; MICROBIAL COMMUNITY; MICROBIOME; NONHUMAN; PERITONEUM PSEUDOMYXOMA; PILOT STUDY; PRACTICE GUIDELINE; PROPIONIBACTERIUM; PROTEOBACTERIA; PSEUDOMONAS; RHIZOBIALES; SEQUENCE ANALYSIS; TISSUE CULTURE; TREATMENT DURATION;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; CULTURE MEDIA; HUMANS; IN SITU HYBRIDIZATION; MICROBIOTA; MUCIN-2; MUCINS; PERITONEAL NEOPLASMS; PERITONEUM; PROGNOSIS; PSEUDOMYXOMA PERITONEI; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84880021658     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-8-105     Document Type: Article

References (39)

1. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Gough DB, Donohue JH, Schutt AJ, Gonchoroff N, Goellner JR, Wilson TO, Naessens JM, O'Brien PC, van Heerden JA, Ann Surg 1994 219 112 119 10.1097/00000658-199402000-00002 8129481 (Pubitemid 24064067)
2. Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells. O'Connell JT, Tomlinson JS, Roberts AA, McGonigle KF, Barsky SH, Am J Pathol 2002 161 551 564 10.1016/S0002-9440(10)64211-3 12163380 (Pubitemid 36142164)
3. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei" Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM, Am J Surg Pathol 1995 19 1390 1408 10.1097/00000478-199512000-00006 7503361
4. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study. Loungnarath R, Causeret S, Bossard N, Faheez M, Sayag-Beaujard AC, Brigand C, Gilly F, Glehen O, Dis Colon Rectum 2005 48 1372 1379 10.1007/s10350-005-0045-5 15909071 (Pubitemid 40933864)
5. [Pseudomyxoma peritonei: new concept and new therapeutic approach]. Loungnarath R, Causeret S, Brigand C, Gilly FN, Glehen O, Ann Chir 2005 130 63 69 10.1016/j.anchir.2004.09.016 15737316 (Pubitemid 40298909)
6. Mucin as a therapeutic target in pseudomyxoma peritonei. Choudry HA, O'Malley ME, Guo ZS, Zeh HJ, Bartlett DL, J Surg Oncol 2012 106 7 911 917 10.1002/jso.23146 22585683
7. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Shen P, Hawksworth J, Lovato J, Loggie BW, Geisinger KR, Fleming RA, Levine EA, Ann Surg Oncol 2004 11 178 186 10.1245/ASO.2004.05.009 14761921 (Pubitemid 40486793)
8. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Witkamp AJ, de Bree E, Kaag MM, van Slooten GW, van Coevorden F, Zoetmulder FA, Br J Surg 2001 88 458 463 10.1046/j.1365-2168.2001.01701.x 11260116 (Pubitemid 32238713)
9. Prognostic significance of lymph node metastases in patients with high-grade appendiceal cancer. Halabi HE, Gushchin V, Francis J, Athas N, Macdonald R, Nieroda C, Studeman K, Sardi A, Ann Surg Oncol 2012 19 122 125 10.1245/s10434-011-1903-0 21748246
10. Pseudomyxoma peritonei: is disease progression related to microbial agents? A study of bacteria, MUC2 AND MUC5AC expression in disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. Semino-Mora C, Liu H, McAvoy T, Nieroda C, Studeman K, Sardi A, Dubois A, Ann Surg Oncol 2008 15 1414 1423 10.1245/s10434-007-9778-9 18299935
11. Moving pictures of the human microbiome. Caporaso JG, Lauber CL, Costello EK, Berg-Lyons D, Gonzalez A, Stombaugh J, Knights D, Gajer P, Ravel J, Fierer N, et al. Genome Biol 2011 12 50 10.1186/gb-2011-12-5-r50 21624126
12. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA, Holt RA, Genome Res 2012 22 299 306 10.1101/gr.126516.111 22009989
13. Bacterial community variation in human body habitats across space and time. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R, Science 2009 326 1694 1697 10.1126/science.1177486 19892944
14. An ecological and evolutionary perspective on human-microbe mutualism and disease. Dethlefsen L, McFall-Ngai M, Relman DA, Nature 2007 449 811 818 10.1038/nature06245 17943117 (Pubitemid 47598621)
15. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Dethlefsen L, Relman DA, Proc Natl Acad Sci USA 2011 108 Suppl 1 4554 4561 20847294
16. The role of microbes in Crohn's disease. Eckburg PB, Relman DA, Clin Infect Dis 2007 44 256 262 10.1086/510385 17173227 (Pubitemid 46079991)
17. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, Ojesina AI, Jung J, Bass AJ, Tabernero J, et al. Genome Res 2012 22 292 298 10.1101/gr.126573.111 22009990
18. Vaginal microbiome of reproductive-age women. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, Karlebach S, Gorle R, Russell J, Tacket CO, et al. Proc Natl Acad Sci USA 2011 108 Suppl 1 4680 4687 20534435
19. Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease. Scanlan PD, Shanahan F, O'Mahony C, Marchesi JR, J Clin Microbiol 2006 44 3980 3988 10.1128/JCM.00312-06 16988018 (Pubitemid 44737239)
20. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Sibley CD, Parkins MD, Rabin HR, Duan K, Norgaard JC, Surette MG, Proc Natl Acad Sci USA 2008 105 15070 15075 10.1073/pnas.0804326105 18812504
21. Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Tannock GW, Munro K, Harmsen HJ, Welling GW, Smart J, Gopal PK, Appl Environ Microbiol 2000 66 2578 2588 10.1128/AEM.66.6.2578-2588.2000 10831441 (Pubitemid 30353968)
22. Bacterial assemblages of the eastern Atlantic Ocean reveal both vertical and longitudinal biogeographic signatures. Friedline CJ, Franklin RB, McCallister SL, Rivera MC, Biogeosci 2012 9 2177 2193 10.5194/bg-9-2177-2012
23. Exploring microbial diversity and taxonomy using SSU rRNA hypervariable tag sequencing. Huse SM, Dethlefsen L, Huber JA, Mark Welch D, Relman DA, Sogin ML, PLoS Genet 2008 4 1000255 10.1371/journal.pgen.1000255 19023400
24. Galaxy: a platform for interactive large-scale genome analysis. Giardine B, Riemer C, Hardison RC, Burhans R, Elnitski L, Shah P, Zhang Y, Blankenberg D, Albert I, Taylor J, et al. Genome Res 2005 15 1451 1455 10.1101/gr.4086505 16169926 (Pubitemid 41400913)
25. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, et al. Appl Environ Microbiol 2009 75 7537 7541 10.1128/AEM.01541-09 19801464
26. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Wang Q, Garrity GM, Tiedje JM, Cole JR, Appl Environ Microbiol 2007 73 5261 5267 10.1128/AEM.00062-07 17586664 (Pubitemid 47326658)
27. Statistical methods for detecting differentially abundant features in clinical metagenomic samples. White JR, Nagarajan N, Pop M, PLoS Comput Biol 2009 5 1000352 10.1371/journal.pcbi.1000352 19360128
28. Antibiotic treatment decreases microbial burden associated with pseudomyxoma peritonei and affects beta-catenin distribution. Semino-Mora C, Testerman TL, Liu H, Whitmire JM, Studeman K, Jia Y, McAvoy TJ, Francis J, Nieroda C, Sardi A, et al. Clin Cancer Res 2013 In press
29. Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. Cox MJ, Allgaier M, Taylor B, Baek MS, Huang YJ, Daly RA, Karaoz U, Andersen GL, Brown R, Fujimura KE, et al. PLoS One 2010 5 11044 10.1371/journal.pone.0011044 20585638
30. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. Huang YJ, Kim E, Cox MJ, Brodie EL, Brown R, Wiener-Kronish JP, Lynch SV, OMICS 2010 14 9 59 10.1089/omi.2009.0100 20141328
31. Association between Streptococcus milleri and abscess formation after appendicitis. Hardwick RH, Taylor A, Thompson MH, Jones E, Roe AM, Ann R Coll Surg Engl 2000 82 24 26 10700762 (Pubitemid 30032217)
32. Clinical and bacterial features of infections caused by Streptococcus milleri. Molina JM, Leport C, Bure A, Wolff M, Michon C, Vilde JL, Scand J Infect Dis 1991 23 659 666 10.3109/00365549109024289 1815325
33. The Streptococcus milleri group-an unrecognized cause of disease in cystic fibrosis: a case series and literature review. Parkins MD, Sibley CD, Surette MG, Rabin HR, Pediatr Pulmonol 2008 43 490 497 10.1002/ppul.20809 18383109 (Pubitemid 351657317)
34. The Streptococcus milleri group as a cause of pulmonary infections. Shinzato T, Saito A, Clin Infect Dis 1995 21 Suppl 3 238 243 8749672
35. Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. Duan K, Dammel C, Stein J, Rabin H, Surette MG, Mol Microbiol 2003 50 1477 1491 10.1046/j.1365-2958.2003.03803.x 14651632 (Pubitemid 38010446)
36. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. Blaser MJ, J Infect Dis 1990 161 626 633 10.1093/infdis/161.4.626 2181029 (Pubitemid 20120217)
37. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Hatakeyama M, Nat Rev Cancer 2004 4 688 694 15343275 (Pubitemid 39215067)
38. Diversified pattern of the human colorectal cancer microbiome. Geng J, Fan H, Tang X, Zhai H, Zhang Z, Gut Pathog 2013 5 2 10.1186/1757-4749-5-2 23497613
39. Prevalence of Propionibacterium acnes in diseased prostates and its inflammatory and transforming activity on prostate epithelial cells. Fassi Fehri L, Mak TN, Laube B, Brinkmann V, Ogilvie LA, Mollenkopf H, Lein M, Schmidt T, Meyer TF, Bruggemann H, Int J Med Microbiol 2011 301 69 78 10.1016/j.ijmm.2010. 08.014 20943438